SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont (NEM) is trending due to mixed reactions to its recent earnings, with some investors citing a double beat and bullish gold forecasts, while others point to weak cash flow and increased debt. Community members are debating the significance of the earnings release and the new CEO's performance, alongside gold price movements. Technical analysts are also weighing in, noting a potential Elliott Wave breakout.

$BALLIN is the perfect meme for everyone showing up every single day.  To be BALLIN, you gotta B-All-In.  The meaning to B All In doesn't only apply to the funds you invest.  It's about dedication.   The countless hours of research.   The endless raiding and working for your bags.  Not knowing how to quit while everyone is telling you you're wrong.  It's about believing in something.  Keep $BALLIN

B All In

B All In (BALLIN) is trending as users promote the token and encourage others to buy, touting potential gains. Community members are highlighting its availability on Phantom Wallet and suggesting it embodies a luxurious lifestyle. However, some users are cautioning against the hype, labeling it a potential scam.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF ($BTC) is trending amid Bitcoin's price volatility and discussions around potential market manipulation. Community members are debating future price targets, with some pointing to potential bullish catalysts and others expressing caution. Broader market themes, such as the relationship between Bitcoin and gold, are also influencing the conversation.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

INBX is trending following news of a potential accelerated approval pathway for INBRX-101, which has sparked significant community discussion.  Traders are actively discussing the possibility of a near-term stock offering, typical for biotech companies after positive announcements, while analysts are updating price targets and reiterating positive ratings for the stock.

STMicroelectronics NV is a global semiconductor company, which engages in the business of designing, developing, manufacturing, and marketing products used in a wide variety of applications for automotive, industrial, personal electronics and communications equipment, computers, and peripherals. It operates through the following segments: Automotive and Discrete Group (ADG), Analog, MEMS, and Sensors Group (AMS), Microcontrollers and Digital ICs Group (MDG), and Others. The ADG segment includes dedicated automotive integrated circuits and discrete and power transistor products. The AMS segment offers analog, smart power, MEMS sensors and actuators, and optical sensing solutions. The MDG segment focuses on general-purpose microcontrollers and microprocessors, connected security products, memories, and RF and communications products. The Others segment is involved in sales assembly services and other revenues. The company was founded in June 1987 and is headquartered in Plan-Les-Ouates, Switzerland.

ST Microelectronics - New York Shares

STMicroelectronics NV

STM is trending as news circulates regarding potential alternative chip supplier negotiations with Volkswagen, sparking community interest due to STM's proximity to VW production. Additionally, the stock is seeing increased interest due to several recent announcements, including advancements in AI datacenter technology and photonics. The community is also following analyst price target updates and European consortium involvement in next-generation silicon photonics.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers (DECK) is trending due to a mixed reaction to earnings, with slowing sales and cautious outlook weighing on the stock despite beating expectations; the community debates whether buybacks can move the stock and if the company needs a new catalyst. Community members are actively discussing potential recovery levels, swing trade opportunities, and the long-term value proposition amid volatility, with some highlighting strong brand performance and others citing concerns about consumer demand and tariffs.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power ($SMR) is trending as investors discuss the potential impact of increasing energy demand from AI and data centers, with some highlighting its advancements in small modular reactor (SMR) technology. Community members are also following news related to government initiatives in the nuclear sector and comparing $SMR's valuation and progress against peers. Additionally, some traders are noting technical indicators that suggest a possible breakout.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is trending amid broader discussions around meme coins and their potential for wealth generation, with some traders comparing it to other popular meme coins like Doge and Shiba Inu. Community members are actively discussing entry points, dip-buying strategies, and whether Pepe can reach new all-time highs. The conversation also includes speculation about market manipulation and the impact of broader economic factors on the crypto market.

GE Vernova, Inc. is a electric power industry. Its products and services generate, transfer, orchestrate, convert, and store electricity. The firm operates through the following segments: Power, Wind and Electrification. The Power segment includes design, manufacture, and servicing of gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. The Electrification segment includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The Company was founded November 09, 2021 and is headquartered in Cambridge, Massachusetts.

GE Vernova Inc.

GE Vernova ($GEV) is trending due to increased attention surrounding the surge in electricity demand for AI data centers, with the community actively discussing target price increases and the company's strategic positioning in the energy sector. Bullish sentiment is fueled by GE Vernova's potential to reach new all-time highs as a key player in the energy transition and AI infrastructure buildout. Some investors express caution about a possible pullback.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending due to increased interest surrounding its AI infrastructure and recent partnership with Palantir. The community is discussing the potential impact of this collaboration, particularly how it could drive growth and improve the company's market position, along with its existing partnerships with other hyperscalers. Attention is also focused on upcoming earnings and the company's overall strategic shift towards AI-driven solutions, but some are concerned about the company's debt.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hinge Health unveils new AI-powered care tools

Hinge Health, Inc. (NYSE:HNGE) today announced two AI-powered care tools: Movement Analysis uses computer vision to set a new standard for tracking musculoskeletal (MSK) outcomes, and Robin is an AI...

Hinge Health received widespread bullish initiation coverage on Monday from a dozen brokerages, with analysts highlighting its leadership in digital musculoskeletal (MSK) care, strong margins, and scalable AI platform.The stock ended 3.9% higher at $36.21 on Monday.Piper SandlerPiper Sandler started the stock at ‘Overweight’ with a $41 target, noting Hinge’s proprietary technology and sophisticated distribution strategy as drivers for sustained double-digit revenue growth.&nbsp;The firm pointed to a 2.4x or greater return on investment across commercial and Medicare populations, with durable 80%-plus gross margins and operating leverage as the company scales beyond its 2,250 clients and 20 million contracted lives as of Dec. 31, 2024.CanaccordCanaccord also began with a ‘Buy’ rating and a $52 target, describing Hinge as a “true innovator” disrupting traditional physical therapy through an AI-powered platform.&nbsp;The firm cited automation of 95% of care and emphasized the defensibility of Hinge’s position in the digital MSK market.BofABofA launched coverage with a ‘Buy’ rating and $42 target, calling Hinge the “digital physical therapy leader” with competitive advantages in its customer base, motion-tracking tech, and partnerships with five of the largest U.S. health plans.NeedhamNeedham began coverage with a ‘Buy’ rating and $47 target, calling Hinge the market leader in virtual MSK care and pointing to its advantages over digital competitors and legacy in-person providers.&nbsp;The firm noted that while 40% of Americans suffer from MSK issues, only 9% get treatment, creating a large untapped opportunity.William BlairWilliam Blair rated the stock ‘Outperform’ and described it as a core healthcare technology holding.&nbsp;The firm pointed to Hinge’s personalized digital app and supportive valuation at 5x 2026 revenue and 6.4x adjusted gross profit.Evercore ISIEvercore ISI also rated the stock ‘Outperform’ with a $50 target, citing broad employer and plan adoption and a multi-condition offering that supports continued 20% annual growth.TruistTruist gave it a ‘Buy’ rating and&nbsp;a $48 target, highlighting “enduring structural advantages,” strong outcomes data, and a flywheel driven by AI, partner networks, and attractive economics.StifelStifel started Hinge with a ‘Buy’ and $48 target, describing a platform that combines mobile app-based care with messaging and licensed PTs.&nbsp;The firm noted that Hinge became profitable and free cash flow positive in 2024, with room for further margin gains.RBC CapitalRBC Capital gave an ‘Outperform’ rating and&nbsp;a $45 target, saying the firm is well-positioned to scale digital MSK care across commercial, Medicare Advantage, and global markets, supported by strong validation and 20M covered lives.KeyBancKeyBanc began with an ‘Overweight’ and $45 target, describing Hinge as the clear leader in a large and underserved healthcare segment.&nbsp;The firm believes the recent 17% decline in share price post-IPO presents an attractive entry point.BarclaysBarclays also rated the stock ‘Overweight’ with a $43 target, saying Hinge can “bend the cost curve” in MSK with its tech and partnerships, and sees 15–20% billings growth translating into 20% revenue expansion.On Stocktwits, retail sentiment was ‘bearish’ amid ‘low’ message volume.The stock has declined 3.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Hinge Health logo is seen displayed on a smartphone and in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)

Wall Street Turns Bullish On Hinge Health As Analysts Laud Profitable Growth, AI Disruption In MSK Care

Analysts noted Hinge Health’s strong return on investment, rapid automation of care delivery, and profitability milestones as key drivers of their bullish stance.

Equity

Wall Street analysts start with bullish ratings on Hinge Health on growth potentia

Investing.com -- Shares of  Hinge Health  Inc (NYSE:HNGE) drew bullish coverage from several brokerages as analysts cited the company’s position as a leading provider of virtual physical therapy and highlighted its expanding market opportunity, improving margins, and adoption of artificial intelligence.

Virtual&nbsp;healthcare provider Omada Health&nbsp;(OMDA)&nbsp;priced its initial public offering (IPO) at $19 per share,&nbsp;at the midpoint of the previously estimated price range of $18 and $20 per share&nbsp;as per an amendment to the S-1 filing made in late May.The offering is expected to close on&nbsp;June 9.The San Francisco-based company&nbsp;would sell&nbsp;7.9 million shares of its common stock. Based on the IPO pricing, the company is set to raise gross proceeds of over $150 million.Additionally, Omada Health has given underwriters a 30-day option to buy up to 1.2 million&nbsp;additional&nbsp;shares of common stock at the IPO price, excluding underwriting discounts and commissions.At the IPO price, Omada is valued at around $1.1 billion, with the potential for a higher valuation on a fully diluted basis. It had raised $192 million in a Series E funding round led by Fidelity Management &amp; Research in February 2022.The shares are set to begin trading on the Nasdaq Global Select Market under the ticker symbol “OMDA” on June 6, 2025.Morgan Stanley, Goldman Sachs &amp; Co, and J.P. Morgan are serving as lead book-running managers for the offering. Barclays and Evercore ISI are acting as joint book-running managers, while Canaccord Genuity and Needham &amp; Company are serving as co-managers.Last month, digital physical therapy company Hinge Health&nbsp;debuted on the NYSE at $39.25 per share, 23% higher than its&nbsp;IPO price of $32. The shares have risen 20% since then.Omada provides virtual care programs designed to help patients manage chronic conditions such as prediabetes, diabetes, and hypertension. According to the prospectus, its revenue increased by 57% year-on-year to $55 million in the quarter ended March 31, 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, an IPO (Initial public offering) words are seen on a smartphone screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Omada Health Prices $150M IPO In-Line With Estimated Range

Omada Health (OMDA) priced its IPO at $19 per share, midpoint of the previously estimated price range of $18.00 and $20.00 per share

Omada Health (OMDA) priced its IPO at $19 per share, midpoint of the previously estimated price range of $18 and $20 per share

Shares of California-based Hinge Health, Inc. (HNGE) jumped 19% above its initial public offering price on Thursday in its debut on the New York Stock Exchange (NYSE).Shares of the company, which leverages software to automate care for joint and muscle health, opened at $39.2 before paring back some gains.<a href="https://stocktwits.com/symbol/HNGE">Hinge</a> said on Wednesday that the company and some of its selling stockholders sold 13.67 million shares of its common stock at an initial public offering price of $32 to raise about $437.3 million. &nbsp;Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg and is backed by venture capital firm Insight Partners. It announced its intent to go public in March.The firm made revenue of $123.8 million in the first quarter and net income of $17.1 million.A Stocktwits user opined that the stock might be “worth watching.”<stembedurl>https://stocktwits.com/ReWorkinvest/message/615490699</stembedurl>Connected TV advertising platform MNTN (MNTN), of which actor Ryan Reynolds is Chief Creative Director, also debuted on the NYSE on Thursday. Shares of the Austin-based company opened at $21, up 31% from its IPO price of $16.Blackrock-backed <a href="https://stocktwits.com/symbol/MNTN">MNTN</a> had reportedly put its IPO ambitions on hold in early April after President Donald Trump’s tariffs stirred up market turmoil.However, the recently announced 90-truce between China and the U.S, which resulted in significantly reduced tariffs on imports, has rekindled market confidence.Last week, Israeli multi-asset investment and social trading company eToro (<a href="https://stocktwits.com/symbol/ETOR">ETOR</a>) debuted on Nasdaq and opened at $69.69, up from its IPO price of $52.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/lightspeed-commerce-q4-2025-earnings/ch09kuhRbpy">Lightspeed Commerce Stock Slides As Impairment Charge Hits Earnings: But Retail’s Optimistic</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hinge Health, MNTN Shares Soar In NYSE Debut

Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg and is backed by venture capital firm Insight Partners.

Hinge Health IPO surges 23% on debut

Investing.com -- Today’s IPO for healthcare service  Hinge Health  Inc (NYSE:HNGE) opened for trading at $39.25 per share after pricing 13,666,000 shares of common stock at $32 per share, the top end of the expected $28-$32 range.

Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. It leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. The firm has designed its platform to address a broad spectrum of MSK care, ranging from acute injury, to chronic pain, to post-surgical rehabilitation, and the platform can help to ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere. The company was founded by Daniel Perez and Gabriel Mecklenburg in 2014 and is headquartered in San Francisco, CA.

HNGE
Hinge Health, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HNGE News

HNGEHinge Health, Inc.